General Atlantic LLC
- SEC CIK
- 0001017645
- Latest filing
- Aug 14, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 15, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 12
- −1 vs. Q4 2025
- Portfolio value
- $2.15B
- −$724.3M (−25.2%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DLOdLocal Ltd | CLASS A COM | 46,656,695 | $605.1M | 28.2% | 00.0% | Unchanged | History |
| CHYMChime Financial, Inc. | COM SHS CL A | 21,259,683 | $398.2M | 18.5% | 00.0% | Unchanged | History |
| XPXP Inc. | CL A | 20,566,133 | $391.6M | 18.2% | −2,133,000−9.4% | Reduced | History |
| ALKTAlkami Technology, Inc. | Stock | 15,337,495 | $240.3M | 11.2% | +3,346,015+27.9% | Added | History |
| PHVSPharvaris N.V. | COM | 8,031,252 | $226.9M | 10.6% | 00.0% | Unchanged | History |
| EWCZEuropean Wax Center, Inc. | CLASS A COM | 13,110,492 | $75.8M | 3.5% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 707,791 | $68.8M | 3.2% | −2,105,137−74.8% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 4,101,865 | $63.6M | 3.0% | −795,294−16.2% | Reduced | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,354,830 | $53.8M | 2.5% | −4,762,885−77.9% | Reduced | History |
| RSKDRiskified Ltd. | SHS CL A | 5,324,998 | $20.9M | 1.0% | 00.0% | Unchanged | History |
| GROVGrove Collaborative Holdings, Inc. | COM CL A | 2,474,859 | $3.17M | 0.1% | 00.0% | Unchanged | History |
| BULLWebull Corp | ORD SHS | 50,816 | $243.9K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2025 (1)
Positions held at the end of Q4 2025 that are gone from this filing.